HIV-1 subtypes and recombinants in the Republic of Congo

被引:38
作者
Niama, Fabien Roch
Toure-Kane, Cournba
Vidal, Nicole
Obengui, Pani
Bikandou, Blaise
Nkodia, Marie Yvonne Ndoundou
Montavon, Celine
Diop-Ndiaye, Halimatou
Mornbouli, Jean Vivien
Mokondzimobe, Etienne
Diallo, Aissatou Gaye
Delaporte, Eric
Parra, Henri-Joseph
Peeters, Martine
Mboup, Souleymane
机构
[1] Hop Le Dantec, Lab Bacteriol & Virol, Dakar, Senegal
[2] IRD, UMR 145, Montpellier, France
[3] CHU Brazzaville, Serv Malad Infect, Brazzaville, Rep Congo
[4] Natl Lab Publ Hlth Congo, Brazzaville, Rep Congo
关键词
HIV; subtypes recombination; evolution; Congo;
D O I
10.1016/j.meegid.2005.12.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
To document the actual genetic diversity of HIV-1 strains in the Republic of Congo, 114 HIV-1 positives persons were sampled in 2003 and 2004 after their informed consent. They were attending the teaching hospital, the reference health center in Makelekele, Brazzaville and the regional hospital centers in Pointe-Noire, Gamboma and Ouesso. A total of 104 samples were genetically characterized by direct sequencing of the p24 gag region and 80 were also subtyped in the V3-V5 env region. The genetic subtype distribution of the Congolese strains showed the predominance of subtype A (36.5% and 32.5% in gag and env, respectively) and G (30.8% and 21.25%), whereas subtype D strains represented 12.5% and 15%. Subtypes C, F, H, J, K and the CRFs-01, -02, -05 -06, and also the recently characterized CRF18 were seen at lower rates. Finally, 4.8% (gag) and 6.25% (env) of the strains could not be classified. Moreover, a high intra-subtype diversity was observed in our study. Among 70 strains which have been characterized in the two genomic regions, 14 (20%) appeared to be unique recombinants. These data show a high genetic variability in the Republic of Congo, where all the subtypes have been documented together with certain subsubtypes and several CRFs. (c) 2006 B.V. All rights reserved.
引用
收藏
页码:337 / 343
页数:7
相关论文
共 29 条
[1]  
Abecasis A., 2005, Infection Genetics and Evolution, V5, P231, DOI 10.1016/j.meegid.2004.07.007
[2]   Genetic Subtyping of gag and env regions of HIV type 1 isolates in Republic of Congo [J].
Bikandou, B ;
Ndoundou-Nkodia, MY ;
Niama, FR ;
Ekwalanga, M ;
Obengui, O ;
Taty-Taty, R ;
Parra, HJ ;
Saragosti, S .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (09) :1005-1009
[3]   Genetic subtypes of HIV type 1 in Republic of Congo [J].
Bikandou, B ;
Takehisa, J ;
Mboudjeka, I ;
Ido, E ;
Kuwata, T ;
Miyazaki, Y ;
Moriyama, H ;
Harada, Y ;
Taniguchi, Y ;
Ichimura, H ;
Ikeda, M ;
Ndolo, PJ ;
Nzoukoudi, MY ;
M'Vouenze, R ;
M'Pandi, M ;
Parra, HJ ;
M'Pelé, P ;
Hayami, M .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (07) :613-619
[4]   HIV-1CRF09_cpx circulates in the North West province of Cameroon where CRF02_AG infections predominate and recombinant strains are common [J].
Burda, ST ;
Konings, FAJ ;
Williams, CAU ;
Anyangwe, C ;
Nyambi, PN .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (12) :1358-1363
[5]   Genetic subtyping and V3 serotyping of HIV type 1 isolates in Congo [J].
Candotti, D ;
Tareau, C ;
Barin, F ;
Joberty, C ;
Rosenheim, M ;
M'Pele, P ;
Huraux, JM ;
Agut, H .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (03) :309-314
[6]   GENETIC-RELATIONSHIPS DETERMINED BY A DNA HETERODUPLEX MOBILITY ASSAY - ANALYSIS OF HIV-1 ENV GENES [J].
DELWART, EL ;
SHPAER, EG ;
LOUWAGIE, J ;
MCCUTCHAN, FE ;
GREZ, M ;
RUBSAMENWAIGMANN, H ;
MULLINS, JI .
SCIENCE, 1993, 262 (5137) :1257-1261
[7]   Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: In vitro phenotypic and genotypic analyses [J].
Descamps, D ;
Collin, G ;
Letourneur, F ;
Apetrei, C ;
Damond, F ;
LoussertAjaka, I ;
Simon, F ;
Saragosti, S ;
BrunVezinet, F .
JOURNAL OF VIROLOGY, 1997, 71 (11) :8893-8898
[8]  
FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
[9]   Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: Implications for vaccine and antiretroviral control strategies [J].
Gordon, M ;
De Oliveira, T ;
Bishop, K ;
Coovadia, HM ;
Madurai, L ;
Engelbrecht, S ;
van Rensburg, EJ ;
Mosam, A ;
Smith, A ;
Cassol, S .
JOURNAL OF VIROLOGY, 2003, 77 (04) :2587-2599
[10]  
Kandathil AJ, 2005, INDIAN J MED RES, V121, P333